Nonhormonal selective estrogen receptor modulator 1 ‐(2‐[4‐{(3R,4S)‐7‐Methoxy‐2, 2‐dimethyl‐3‐phenyl‐chroman‐4yl}phenoxy]ethyl)pyrrolidine hydrochloride (ormeloxifene hydrochloride) for the treatment of breast cancer

Drug Development Research, EarlyView.

Source: Drug Development Research - October 4, 2018 Category: Drugs & Pharmacology Authors: Lakshmi Sreedharan Pillai, Saikant Regidi, Shiny Deena Varghese, Shilpa Ravindran, Vani Maya, Jesline Varghese, Kartik Ramaswami, Rajmohan Gopimohan, Manoj Gopi Source Type: research